1. Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias;Grutzmacher;Clinical research in cardiology supplements,2015
2. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography, Atherosclerosis;Safarova;Supplement,2013
3. Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels;Schettler;Clinical research in cardiology supplements,2019
4. Evolocumab: first global approval;Markham;Drugs,2015
5. Evolocumab and clinical outcomes in patients with cardiovascular disease;Sabatine;N Engl J Med,2017